Veracyte Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Veracyte Inc 's inventory turnover ratio sequentially decreased to 3.23 in the third quarter 2026, unsurprisingly, as the Veracyte Inc markets continue to deteriorate, and VCYT's faces growing challenges to bring down its inventories. Veracyte Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 113 days, from 75 days, in the Jun 30 2026 quarter.

Within Healthcare sector 75 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 607 in the second quarter 2026, to 631.

VCYT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Veracyte Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VCYT Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	27.01 %	-9.45 %	-11.7 %	-5.54 %	-0.18 %
Y / Y Cost of Sales Growth	-90.11 %	-91.43 %	17.86 %	6.18 %	13.79 %
Inventory Turnover Ratio (TTM)	3.23	4.84	6.05	5.64	5.47
VCYT's Total Ranking	# 631	# 607	# 535	# 325	#
Average inventory processing period	113	75	60	65	67
Seq. Inventory Growth	13.96 %	5.79 %	4.23 %	1.08 %	-18.76 %
Seq. Cost of Sales Growth	19.12 %	-91.69 %	-2.94 %	3.03 %	3.13 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 6
Healthcare Sector	# 76
Overall Market	# 631

Inventory Turnover Ratio Statistics
High	Average	Low
19.97	7.07	3.97
(Mar 31 2014)		(Jun 30 2020)

VCYT Company Profile >> Back to VCYT Efficiency Comparisons >> Compare VCYT Inventory Turnover Ratio to its Competitors

Financial Statements
Veracyte Inc 's Inventories	$ 26 Millions	Visit VCYT's Balance sheet
Veracyte Inc 's Cost of Revenues TTM	$ 73 Millions	Visit VCYT's Income Statement
What are VCYT's Sales?		Visit VCYT's Sales by Segment

Other Inventory Turnover Ratios
Veracyte Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VCYT's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VCYT's Competitors
Inventory Turnover Ratio for VCYT's Suppliers
Inventory Turnover Ratio for VCYT's Customers

You may also want to know
VCYT's Sales Growth Rates	VCYT's Pe Price to earnings ratio	VCYT's Receivables Turnover Ratio	VCYT's Stock Quote
VCYT's Net Income Growth Rates	VCYT's Ps Price to Sales ratio	VCYT's Sales per Employee	VCYT's Asset Turnover Ratio
VCYT's Net Margin	VCYT's Pb Price to Book ratio	VCYT's Financial Strength Ratios	VCYT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Phathom Pharmaceuticals Inc	7.76	$ 53.106 Millions	$ 7 Millions
Novavax inc	7.03	$ 90.533 Millions	$ 13 Millions
Carlisle Companies Incorporated	6.99	$ 3,406.400 Millions	$ 488 Millions
Cardiff Lexington Corporation	6.98	$ 3.768 Millions	$ 1 Millions
Carlsmed Inc	6.91	$ 15.844 Millions	$ 2 Millions
Caredx Inc	6.42	$ 111.106 Millions	$ 17 Millions
Edap Tms Sa	6.14	$ 60.833 Millions	$ 10 Millions
Transmedics Group Inc	5.70	$ 301.220 Millions	$ 53 Millions
Bristol myers Squibb Company	5.65	$ 15,389.000 Millions	$ 2,722 Millions
Avantor Inc	5.48	$ 4,539.200 Millions	$ 828 Millions
Tactile Systems Technology Inc	5.25	$ 82.718 Millions	$ 16 Millions
Integer Holdings Corporation	4.98	$ 1,376.268 Millions	$ 276 Millions
Ge Healthcare Technologies Inc	4.69	$ 11,372.000 Millions	$ 2,425 Millions
West Pharmaceutical Services Inc	4.69	$ 2,120.200 Millions	$ 452 Millions
Henry Schein Inc	4.63	$ 9,395.000 Millions	$ 2,031 Millions
Cryoport inc	4.60	$ 102.157 Millions	$ 22 Millions
Myomo Inc	4.58	$ 14.802 Millions	$ 3 Millions
Idexx Laboratories Inc	4.52	$ 1,743.379 Millions	$ 386 Millions
Autolus Therapeutics Plc	4.34	$ 88.293 Millions	$ 20 Millions
Medinotec Inc	4.28	$ 5.143 Millions	$ 1 Millions
Electromed Inc	4.18	$ 14.878 Millions	$ 4 Millions
Intelligent Bio Solutions Inc	4.14	$ 2.206 Millions	$ 1 Millions
3m Company	4.02	$ 15,267.000 Millions	$ 3,801 Millions
Novocure Limited	3.98	$ 166.721 Millions	$ 42 Millions
Sonoma Pharmaceuticals Inc	3.90	$ 14.275 Millions	$ 4 Millions
Koru Medical Systems Inc	3.88	$ 16.831 Millions	$ 4 Millions
Incyte Corporation	3.79	$ 439.399 Millions	$ 116 Millions
Baxter International Inc	3.57	$ 8,117.000 Millions	$ 2,277 Millions
Bausch Health Companies Inc	3.54	$ 4,518.000 Millions	$ 1,276 Millions
Coherus Oncology inc	3.50	$ 16.193 Millions	$ 5 Millions

Date modified: 2026-11-07T13:19:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.